Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis.
Journal: Alimentary pharmacology & therapeutics
Published: July 13, 2023
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Journal: The New England journal of medicine
Published: June 25, 2023
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.
Journal: Hepatology (Baltimore, Md.)
Published: January 23, 2023
A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 14, 2020
Showing 1-4 of 4
Last Updated: 09/26/2026